This April 20, 2010, file photo shows an exterior view of Amgen offices in California. Amgen Inc. The world's largest biotechnology company announced on Wednesday its plans to build a new manufacturing plant in Singapore. -- PHOTO: AP
By Lee Su Shyan
Amgen, the world's largest independent biotechnology firm, is setting up its first Asian manufacturing facility in Singapore, the Economic Development Board announced.
The US-based, Fortune 500 company, headquartered in California is
expected to invest about US$200 million to build an innovative new facility at
the Tuas Biomedical Park.
EDB's director of Biomedical Sciences Kevin Lai said:
"Amgen's decision is a strong testament to Singapore's track record in
biologics manufacturing. We are proud that the Singapore facility will be
Amgen's first major investment in Asia utilising its state-of-the-art
technology which will transform the future of biologics industry and making
healthcare more affordable."
Source:
-Angeline
